NIH Shares COVID-19 Technologies With Medicines Patent Pool

The National Institutes of Health (NIH) has licensed 11 COVID-19 research tools and early-stage vaccine and diagnostic candidates to the Medicines Patent Pool, a program backed by the United Nations.

Among the technologies being shared is the SARS-CoV-2 stabilized spike protein, a patented invention included in several COVID-19 vaccines.

The newly licensed technologies are also being made available through the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) program, which is meant to share intellectual property, knowledge and data regarding COVID-19 vaccines, therapeutics and diagnostics.

“Sharing our scientific knowledge and health technologies with C-TAP to foster the development of crucial medical countermeasures is another step we are taking to assist our global partners in our shared fight against this devastating disease,” said HHS Secretary Xavier Becerra.